Eric Verdin
- New
- Location: Japan, Osaka
- As a specialist at the clinic, Dr. Eric Verdin (President of the Buck Institute for Research on Aging) is referenced in the clinic’s NAD+ discussion for why intravenous NAD+ may not reach cells effectively. In a conversation with Peter Attia on The Drive (episode #359), he highlighted NAD+’s molecular size and described breakdown into nicotinamide before cellular use. The clinic’s longevity messaging therefore leans toward oral precursors like NMN as a more workable option.
- Read more
Package price from$19,800
